Table 2.

Preoperative characteristics of patients with metastatic disease of the acetabulum.

Patients	Gender	Age	Primary Tumor	Bone/visceral Metastasis	Previous Treatment	ASA Score	ECOG Status	Index Presentation	Harrington Type
1	M	66	Prostate cancer	Multiple/Lung	NO	3	4	Fracture	II
2	M	36	Penile cancer	Solitary/-	NO	2	3	Intractable pain	II
3	F	45	Lung cancer	Multiple/Mediastinal lymph node	NO	2	4	Impending Fracture	II
4	M	64	Bladder cancer	Multiple/Liver	Chemotherapy/Targeted therapy/Radiotherapy	3	4	Intractable pain	II
5	F	48	Gastrointestinal cancer	Multiple/brain	Chemotherapy	3	3	Intractable pain	II
6	F	41	Colon cancer	Multiple/Lung/abdominal lymph node	Chemotherapy/Targeted therapy	3	3	Impending Fracture	II
7	F	42	Lung cancer	Solitary/-	Chemotherapy	2	3	Fracture	III
8	F	53	Thyroid cancer	Multiple/-	Radiotherapy/Targeted therapy	2	3	Impending Fracture	II
9	M	44	Renal carcinoma	Solitary/-	Radiotherapy	3	3	Impending Fracture	III
10	F	44	Lung cancer	Multiple/brain	Radiotherapy/Targeted therapy	3	4	Impending Fracture	III
11	M	61	Renal carcinoma	Multiple/-	NO	2	3	Intractable pain	III
12	M	38	Lung cancer	Multiple/-	Chemotherapy	2	3	Intractable pain	III
13	M	61	Liver cancer	Multiple/-	Radiotherapy/Targeted therapy	3	4	Impending Fracture	III
14	M	56	Colon cancer	Multiple/Lung	Chemotherapy	2	4	Impending Fracture	III
15	F	56	Cervical cancer	Solitary/-	Chemotherapy	3	4	Impending Fracture	III
16	F	34	Lung cancer	Multiple/-	NO	2	3	Intractable pain	III
17	F	37	Cervical cancer	Multiple/Pelvic lymph nodes	NO	2	4	Impending Fracture	III

ASA, American Society of Anesthesiologists; ECOG, Eastern Cooperative Oncology Group.